Transforming online health communities
Find out how the NHS’s online healthcare groups drove patient engagement up by 300%
Mobilising Mozilla’s super-fan communities
Find out how Firefox became the leading browser in Europe
Tapping into the conversation
Find out how Capgemini used social data to optimise its business propositions
Managing events in social media
Find out how Red Bull’s social media team revolutionised their London Music Academy
Creating ‘flash communities’
Find out how Samsung Mobile’s music community earned three million content views in eight weeks
What we do
RMM is a social business consultancy. Since 2006, we have been helping organisations in the UK and Europe use social media to unlock new value from their customer, employee, media and investor relationships.
We have a cross-business silo approach to social, working with marketing, customer experience, product development, operational and HR teams.
How we do it
We use social media to drive growth by creating more connected organisations and more profitable customer relationships.
Our mixed discipline team of social specialists plans, delivers and manages programs of social media activity.
Social Climber 42: the dark side, voicemail and pigeon fanciers
Back in a refreshed monthly format, it’s business as usual as the Social Climber tries to tickle out the real social goodness from around the world.
Methods for measuring the ROI of social media activity
We identify some key trends in measurement methodologies that brands have been using over the past year, to help understand the ROI of social media.
LinkedIn Profiles, New Jobs and Corporate Confidentiality
A post on employers who perceive their employees to be over-sharing on LinkedIn and how organisations can mitigate the reputational risks of the platform
Pharma, Social and Human Research Subjects Recruitment
By Dan O'Connor
It is not a particularly comfortable time for the pharmaceutical industry. Several extremely profitable drugs, such as Lipitor, Zyprexa, and Levaquin, have lost their patents, whilst other big sellers, like Plavix, Seroquel and Singulair, lose theirs this year. With an apparent lack of replacement ‘blockbusters’ in the pipeline, the big, ‘brand-name’ pharmaceutical companies’ profits seem… more